Health

Results: 6241-6252 of 8716

ATTEND FDI WORLD DENTAL FEDERATION'S VIRTUAL SUMMIT SHOWCASING SUSTAINABLE PRACTICES IN DENTISTRY TO REDUCE THE PROFESSION'S ENVIRONMENTAL IMPACT

Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.

Professor Dean Fennell, principal investigator, presents results from the Phase 1 MITOPE clinical study of a first-in-human, and potential first-in-class therapeutic, RSO-021. (Photo: Business Wire)

RS Oncology Announces Positive Data from a Phase 1 Clinical Trial of RSO-021, a First-in-Class Therapeutic for Malignant Pleural Mesothelioma

HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024

Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual Meeting

Evosep Unveils Groundbreaking Innovations in Scalable Proteomics Workflows at ASMS 2024

Novotech Launches Dedicated Early Phase Unit for Biotechs Leveraging the Australian and New Zealand Clinical Environment

Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family

PR Newswire associated0

Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer

YourChoice Therapeutics Completes Phase 1a Clinical Study for First Hormone-Free Male Birth Control Pill

PR Newswire associated0

Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024

Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo